H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

NCT06325696 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

37

Enrollment

NIH

Sponsor class

Conditions

Interstitial Lung Disease
Idiopathic Pulmonary Fibrosis
Lung Diseases, Interstitial

Interventions

DRUG: hymecromone

Sponsor

National Institute of Environmental Health Sciences (NIEHS)